Our innovation reads this week explore the best models to drive change in the health care industry. Plus, drug-delivering contact lenses?
While AI has been a buzzword of late, few companies are making true strides in using the technology in the health care industry. According to an article in Venture Beat, a few technological, psychological and regulatory limitations are hampering AI’s adoption and use in health care. See the full piece for more.
When technology companies aim to upend industries, they typically focus on consumer experience —like Uber changed how we call for cars. In health care, that has proved difficult because “most consumers engage with the system infrequently” and are typically guided by their health plans or physicians, according to the Washington Post. Read the Post’s full take on the challenges confronting companies trying to disrupt the health care industry.
“To accelerate innovation in healthcare technology we need to give creative people who don’t have traditional health science backgrounds more opportunities to participate,” Melissa Schilling, a management professor at New York University, writes in the Harvard Business Review. She outlines some suggestions for how health care veterans can better partner with outsiders for innovation in the full piece.
Instead of relying on industry outsiders to bring change in health care, Dr. John Noseworthy, the outgoing president and CEO of Mayo Clinic, says innovation will happen when stakeholders form new alliances to drive change. Read on for more on his view.
Theraoptix, a startup that created contact lenses that dispense medication to their wearer, won the Massachusetts Institute of Technology’s Sloan Healthcare Innovation Prize and $25,000. The lenses may treat glaucoma or help people heal after eye surgery, both of which conventionally involve eye drops. The startup says the lenses may also treat macular degeneration or diabetic retinopathy, conditions that usually require an injection. Read more from MIT.